UY29378A1 - PHARMACEUTICAL PREPARATION FOR ORAL ANTI-CONCEPTION - Google Patents

PHARMACEUTICAL PREPARATION FOR ORAL ANTI-CONCEPTION

Info

Publication number
UY29378A1
UY29378A1 UY29378A UY29378A UY29378A1 UY 29378 A1 UY29378 A1 UY 29378A1 UY 29378 A UY29378 A UY 29378A UY 29378 A UY29378 A UY 29378A UY 29378 A1 UY29378 A1 UY 29378A1
Authority
UY
Uruguay
Prior art keywords
pharmaceutical preparation
ethinyl estradiol
conception
dienogest
oral anti
Prior art date
Application number
UY29378A
Other languages
Spanish (es)
Inventor
Thoamas Graser
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Priority to UY29378A priority Critical patent/UY29378A1/en
Publication of UY29378A1 publication Critical patent/UY29378A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una preparación farmacéutica para la anticocepción oral, que contiene como primer componente de principio activo 17a-cianometil-17b.hidroxiestra-4,9-dien-3-ona (dienogest) en una dosis diaria de 1,5 mg de dienogest y como segundo componente de principio activo 17a- etinilestradiol (etinilestradiol) en una dosis diaria de 0,015 ó 0,020 mg de etinilestradiol) ó 2,0 mg de dienogest y 0,015 mg de etinilestradiol, se administra junto con uno o varios portadores farmacéuticamente aceptable en al menos 21 días de un ciclo menstrual de 28 días.A pharmaceutical preparation for oral anticoception, containing as the first active ingredient component 17a-cyanomethyl-17b.hydroxystra-4,9-dien-3-one (dienogest) in a daily dose of 1.5 mg of dienogest and as a second Active ingredient component 17a-ethinyl estradiol (ethinyl estradiol) in a daily dose of 0.015 or 0.020 mg ethinyl estradiol) or 2.0 mg of dienogest and 0.015 mg ethinyl estradiol, administered together with one or more pharmaceutically acceptable carriers in at least 21 days of a 28 day menstrual cycle.

UY29378A 2006-02-15 2006-02-15 PHARMACEUTICAL PREPARATION FOR ORAL ANTI-CONCEPTION UY29378A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY29378A UY29378A1 (en) 2006-02-15 2006-02-15 PHARMACEUTICAL PREPARATION FOR ORAL ANTI-CONCEPTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY29378A UY29378A1 (en) 2006-02-15 2006-02-15 PHARMACEUTICAL PREPARATION FOR ORAL ANTI-CONCEPTION

Publications (1)

Publication Number Publication Date
UY29378A1 true UY29378A1 (en) 2006-08-31

Family

ID=38813145

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29378A UY29378A1 (en) 2006-02-15 2006-02-15 PHARMACEUTICAL PREPARATION FOR ORAL ANTI-CONCEPTION

Country Status (1)

Country Link
UY (1) UY29378A1 (en)

Similar Documents

Publication Publication Date Title
HRP20070188A2 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
ES2693085T1 (en) Use of estriol in low doses
CO6160297A2 (en) USE OF ESTRADIOL VALERATE OR 17BETA-ESTRADIOL IN COMBINATION OF DIENOGEST IN AN ORAL THERAPY TO MAINTAIN AND / OR INCREASE THE FEMALE FREE
AR061959A1 (en) PHARMACEUTICAL COMPOSITION FOR CONTRACEPTION AND TO REDUCE THE RISK OF CONGENITAL MALFORMATIONS
CR9324A (en) PHARMACEUTICAL PREPARATION FOR ORAL ANTI-CONCEPTION
EA200701389A1 (en) SOLID ORAL MEDICAL FORM FOR CONTRACEPTION
UY29379A1 (en) PERORAL PHARMACEUTICAL FORM OUTPUT FOR ANTI-CONCEPT
UY29378A1 (en) PHARMACEUTICAL PREPARATION FOR ORAL ANTI-CONCEPTION
TW200731977A (en) Use of estradiol valerate in combination with dienogest for the oral treatment of dysfunctional uterine bleeding in conjunction with oral contraception
CR10912A (en) FRAMACEUTICAL PREPARATION TO REDUCE ENDOMETRIOSIS
CY1110348T1 (en) PHARMACEUTICAL FORM FOR DENTAL ORGANIZATION WITH DIENOGEST AND ETHINYL-OSTRADIOL FOR ANTI-CONTRACT
PE20091020A1 (en) USE OF A GESTAGEN IN COMBINATION WITH A ESTROGEN AND ONE OR MORE PHARMACEUTICALLY ACCEPTABLE EXCIPIENTS / CARRIERS FOR LACTOSE-FREE ORAL CONTRACEPTION
CY1112775T1 (en) USE OF VALERIAN OSTRADIOLIS IN CONNECTION WITH DIENOGEST FOR ORAL TREATMENT OF MUTRAL DISORDER BLOOD TREATMENT IN AITITA
CR9240A (en) SOLID PERORAL PHARMACOLOGICAL FORM FOR ANTI-CONCEPTION
TH80557B (en) Pharmaceutical products for oral contraception
TH80557A (en) Pharmaceutical products for oral contraception
RS50849B (en) Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method
TH80558B (en) Solid oral dosage forms for birth control
TH80558A (en) Solid oral dosage forms for birth control
CU20090116A7 (en) PHARMACEUTICAL PREPARATION TO REDUCE ENDOMETRIOSIS
TH54054B (en) Pharmaceutical mixtures for use as birth control pills
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive
ECSP003721A (en) A PHARMACEUTICAL COMPOSITION TO BE USED AS AN CONTRACEPTIVE

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20090915